Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1161.4000 -11.50 (-0.98%)
NSE Jan 13, 2026 13:01 PM
Volume: 530.7K
 

logo
Aurobindo Pharma Ltd.
10 Feb 2025
1161.40
-0.98%
buy
by Prabhudas Lilladhar
Target: 1510 | Upside : 30.0%
Prabhudas Lilladhar
 
Number of FII/FPI investors decreased from 728 to 700 in Sep 2025 qtr
More from Aurobindo Pharma Ltd.
Recommended
Market trades lower, KPI Green Energy signs Rs 4,000 crore renewable energy pact
Trendlyne Marketwatch | 13 Jan 2026, 01:01PM
IPO wave continues as Amagi Media and Five SMEs open for subscription
| 12 Jan 2026, 06:40PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020